Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy. (30th November 2021) - Okada, Yuri; Izumi, Rumiko; Hosaka, Tatsuhiko; Watanabe, Satoshi; Shijo, Tomomi; Hatchome, Naokazu; Konishi, Risa; Ichimura, Yuki; Okiyama, Naoko; Suzuki, Naoki; Misu, Tatsuro; Aoki, Masashi